Japanese Society of Myeloma

Journal

AIMS & SCOPE

International Journal of Myeloma (IJM) is an international, peer-reviewed, interdisciplinary publication encompassing clinical, physiological, pathological, genetic/cytogenetic and medical research on plasma cell dyscrasias, including multiple myeloma, plasma cell leukemia, plasmacytomas, amyloidosis, POEMS syndrome, and monoclonal gammopathy of undetermined significance. The Journal welcomes original contributions dealing with all aspects of plasma cell dyscrasias, including clinical and fundamental studies. The journal welcomes articles described by either English or Japanese language, while prefers English articles for more world-wide activity.

Online Submission

Authors should submit their manuscripts using the journal's online submission system. Please go directly to the site (https://www.editorialmanager.com/ijmm) and upload all files associated with the manuscript following the instructions given on the screen.

Instruction for Authors

See PDF

JMS Editorial Board

Editor-in-Chief

Chiaki Nakaseko, Chiba, Japan.

Associate Editors

Shinsuke Iida, Aichi, Japan.
Masahiro Abe, Tokushima, Japan.
Tadao Ishida, Hokkaido, Japan.
Masahiro Kizaki, Saitama, Japan.
Junya Kuroda, Kyoto, Japan.
Hiroshi Kosugi, Gifu, Japan
Akira Sakai, Fukushima, Japan.
Takaaki Chou, Niigata, Japan.
Naoya Mimura, Chiba Japan
Akiyoshi Miwa, Tokyo, Japan.

Japanese Editorial Board

Hideki Asaoku, Hiroshima
Ichiro Hanamura, Aichi
Hideo Harigae, Miyagi
Hiroyuki Hata, Kumamoto
Kiyohiko Hatake, Tokyo
Yutaka Hattori, Tokyo
Yoshinobu Kanda, Saitama
Norio Komatsu, Tokyo Shuji Ozaki, Tokushima
Kenichi Sawada, Akita
Chihiro Shimazai, Kyoto
Takashi Sugihara, Okayama
Kenshi Suzuki, Tokyo
Yasushi Takamatsu, Fukuoka